. Author manuscript; available in PMC: 2019 Mar 1.

Published in final edited form as: AIDS Behav. 2018 Mar;22(3):742–751. doi: 10.1007/s10461-017-1826-2

Table 2.

Binary SUD Prediction of HRSA/HAB-Defined Two-Year Care Retention

	Beta value	95% CI (lower, upper)	Standard Error	Wald X²	Odds-Ratio	95% CI (lower, upper)

Patient Attributes
SUD	−.56	(−.15, −.98)	.21	7.18^**	.57	(.38, .86)
Age-Group	.18	(.11, .24)	.03	30.18^**	1.19	(1.12, 1.27)
Sex	.07	(−.09, .23)	.08	.70, ns	1.07	(.91, 1.26)
Care Site	−.05	(−.09, −.01)	.02	5.76^*	.95	(.92, .99)
Interactions
SUD × Age-group	.11	(.02, .20)	.05	6.10^*	1.12	(1.02, 1.22)
SUD × Sex	.07	(−.18, .32)	.13	.29, ns	1.07	(.83, 1.38)
SUD × Site	−.01	(−.06, .05)	.03	.08, ns	.99	(.94, 1.05)

Analyses based on an aggregate patient sample (N = 9153), drawn from seven CNICS care sites.

Two-Year Care Retention computed according to HRSA HAB formulation of two attended visits, separated by at least 90 days, within a calendar year.

SUD identification based on substance-specific diagnostic thresholds from both the AUDIT-C (for alcohol UD) and the ASSIST (for cocaine UD, marijuana UD, methamphetamine UD, and opioid UD).

Odds-ratios reflect the likelihood of two-year care retention.

^***

p<.001,

^**

p<.01,

p<.05.